Multi-luminance mobility testing after gene therapy in the context of retinal functional diagnostics.

"Declarations Ethics approvalThe study was approved by the ethics committee of the University of Tübingen. All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of Tübingen and with the 1964 Helsinki declaration and its later amendments. This article does not contain any studies with animals performed by any of the authors. Informed consentInformed consent was obtained from all participants included in the study. Conflict of interestKatarina Stingl is a consultant for Novartis, ProQR, ViGeneron, Santen, and Janssen, with all fees paid to Center for Ophthalmology, University of Tübingen, to support the research. Friederike Kortüm is a consultant for Novartis. No conflicts of interest for this work. Conflict of interest Katarina Stingl is a consultant for Novartis, ProQR, ViGeneron, Santen, and Janssen, with all fees paid to Center for Ophthalmology, University of Tübingen, to support the research. Friederike Kortüm is a consultant for Novartis. No conflicts of interest for this work."

"Funding Open Access funding enabled and organized by Projekt DEAL."